Today: 29 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna’s stock has pulled back modestly in late October after a strong run earlier in the year. According to market data, CI closed at $299.12 on Oct 29, 2025, down about 3% from the previous closestockanalysis.com. The dip followed weakness in broader managed-care stocks amid concerns about healthcare costs and policy. In pre-market trading Oct 30, CI rebounded to about $303reuters.com. Over the past year, CI shares have traded between roughly $257 and $350stockanalysis.com, reflecting volatility in the insurance sector. Despite the pullback, Cigna’s valuation metrics remain attractive: at ~16x forward earnings, it still trades well below historical levels. Analysts note that a year-long surge left CI ripe for profit-taking. As Morningstar’s Julie Utterback observed, Cigna “maintained the status quo from a 2025 guidance perspective, which is probably what is keeping shares flat”reuters.com. In other words, the company stuck to its outlook, so the stock is trading largely on fundamentals rather than any new surprises.
30 October 2025
···
Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

Estée Lauder shares jumped in early trading after the earnings release. Reuters data show EL pre-market up ~5% to $102.26tradingview.com. By midday Oct. 30 the stock was about $97.36, down ~1.4% on the dayreuters.com. Trading updates noted EL was a top mover on Oct 13 after Goldman’s upgradets2.techts2.tech. Overall, EL is now up nearly 30% year-to-datetradingview.com. The company’s Q1 results far exceeded forecasts. As reported, net sales were $3.481B, up 4% year-over-yearmarketscreener.com. On a non-GAAP basis, sales rose about 3%marketscreener.commarketscreener.com. This marks a return to growth after two years of decline. Importantly, EL turned profitable: GAAP operating income was $169M versus a $121M loss a year agomarketscreener.com, and GAAP net income was $0.13 per sharemarketscreener.com. Adjusted EPS of $0.32 beat the consensus of $0.18tradingview.commarketscreener.com. Management credited tight cost controls and efficiency gains from its turnaround program for the margin improvementmarketscreener.com.
30 October 2025
··
Hot GDP Surprise Shatters Wall Street’s Rally – Stocks Slide on Fed Jitters (Sept 25, 2025)

Stock Market Rollercoaster: Tech Stocks Tumble After Trump-Xi Trade Truce & Fed’s Hawkish Signals

Global stocks wobbled this week on the twin shocks of trade news and monetary policy. In Busan on Oct. 30, Trump met Xi Jinping and touted a deal to trim U.S.–China tariffs, resume Chinese soybean and energy imports, and keep rare-earths exports flowingreuters.com. Beijing promptly agreed to suspend some counter-tariffs for a year. Yet traders remained wary. “A good Trump/Xi meeting was in the price…we’ve simply got confirmation of that,” noted Daiwa’s Chris Scicluna, implying markets had already anticipated a positive outcomereuters.com. In fact, stocks “fell on concerns the truce may prove fleeting” as details were scant. Meanwhile, the Fed’s Oct. 29 announcement of a 25‑bp cut was priced in, but Powell’s press conference cooled hopes for more easing. He cited policy splits and scant data to argue another cut “may be out of reach” in Decemberreuters.comreuters.com. As a result, U.S. 10-year yields rose and the dollar strengthenedreuters.com. Safe-haven assets were bid: gold jumped to ~ $4,000/ozreuters.com and the crypto market weakened in response.
30 October 2025
·······
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo Nordisk’s proposal is unsolicited, meaning Metsera’s board and shareholders will now review it against Pfizer’s agreement. Novo emphasizes that Metsera’s experimental therapies would be “complementary” to its own obesity portfolioreuters.com. According to MarketScreener, the bid is $56.50 in cash per Metsera share plus $21.25 in milestone CVRsmarketscreener.com. By contrast, Pfizer’s September deal was $4.9B upfront plus CVRs, for up to ~$7.3Bts2.techreuters.com. Novo’s offer thus values the company at roughly $6.5B upfront, sweetened to ~$9B with earnouts. Novo’s CEO Maziar “Mike” Doustdar hailed the move as proof of the company’s ambition. In recent acquisitions of non-obesity assets, he said Novo was showing a “relentless ambition to move faster, go further”ts2.tech. The Metsera bid follows a sweeping boardroom shake-up at Novo, where its largest shareholder demanded faster action in the U.S. marketreuters.com. Now Novo is doubling down, essentially offering a higher price to hijack Pfizer’s deal and expand its obesity pipeline.
30 October 2025
····
Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Stock Dips on Earnings Beat — Will Pipeline Boost Spur a Rally?

Merck’s stock price dipped on Oct 30, 2025 even as it delivered a strong third-quarter report. The company posted $17.28 B in Q3 sales and $2.58 adjusted EPS – above analyst forecastsmarketscreener.com. Sales of Keytruda, its blockbuster cancer drug, grew about 10%marketscreener.com, offsetting a drop in Gardasil vaccine revenue. Despite the beat, Merck narrowed its 2025 sales outlook while slightly raising profit guidancemarketscreener.com, a cautious stance that likely weighed on the share price. Beyond the quarterly numbers, recent product news is energizing Merck’s outlook. In September 2025 the FDA approved Keytruda QLEX, a new one- or two-minute subcutaneous injection of Keytrudats2.tech. On Oct. 7, Merck closed its $10 B deal to buy Verona Pharma, gaining Ohtuvayrets2.tech. At the ESMO oncology conference in early October, Merck announced positive Phase 3 results for KEYNOTE-B96 and KEYNOTE-905, and it launched an RSV vaccine called Capvaxivets2.tech. Another late-stage drug, Winrevair, received FDA priority review after showing a 76% reduction in death/hospital events; a decision is due by Oct. 25, 2025ts2.tech. These approvals and trial readouts – along with a broad clinical pipeline – form the basis for Merck’s expectation of renewed growth in H2 2025 and beyond.
30 October 2025
···
Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

On Oct 29 Cambium announced that its ONE Network solution now integrates SpaceX’s Starlink LEO satellite internet Prnewswire. The press release explained this enables “scalable management, visibility, and performance optimization” for enterprise Starlink connections, including multi-WAN bonding, advanced security, and centralized monitoring Prnewswire Benzinga. In other words, Cambium customers can now combine multiple Starlink links into their wired/wireless networks using Cambium’s cnMaestro and NSE platforms. Investors viewed the tie‑up as a game-changer. At market close on Oct 29, CMBM was $2.95, a +377% jump from the prior day Stockanalysis. In after-hours trading the stock spiked over +126%, reaching about $6.69 Benzinga. Pre‑market on Oct 30 it was around $5.80 Stockanalysis. By midday Oct 30 the stock was volatile around multi‑dollar levels. As TipRanks noted, the surge is partly tied to “connections to Musk”, which tend to attract speculative buying Tipranks Tipranks. Trading volume exploded – Benzinga reported over 115 million shares traded, versus a 3‑month average of ~0.25 million Tipranks.
30 October 2025
··
VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

On Oct. 29 after the market closed, VCI Global announced that its unit Smart Bridge Technologies will solely issue and manage 1 billion XVIQ tokens – a new digital asset for AI infrastructure, GPU cloud services and real-world assetsglobenewswire.com. The press release outlined how Smart Bridge will oversee token issuance, a treasury and liquidity to generate fees from GPU services, cybersecurity, token settlement and moreglobenewswire.com. CEO Henry Chai said the mandate is “a pivotal step…[laying] the foundation for a digital financial infrastructure that connects AI, GPU, and real-world asset markets.”globenewswire.com. Within minutes of this news, retail traders piled into the stock. Benzinga reports VCIG closed Wednesday’s regular session at $1.80, then in after-hours trading the stock leaped to $3.38benzinga.com. This volatile surge highlights how thinly-traded penny stocks can swing dramatically on single announcements. As of Oct. 30 midday, VCIG was trading roughly in the same $1.8 regionreuters.com, suggesting profit-taking and price swings are intense.
30 October 2025
····
Inside Samsung: How the Tech Giant is Dominating Every Industry It Touches

Samsung Stock Soars on AI Chip Boom – Q3 Earnings Crush Estimates

Samsung’s share price climbed sharply on October 30 after it disclosed a surprise surge in Q3 earnings. The official results showed revenue of about ₩86.1 trillion and operating profit of roughly ₩12.2 trillion for July–September, well above analysts’ forecastslivemint.comgurufocus.com. The memory chip business was the standout: Samsung said record AI-driven demand led its chip division to post double-digit profit growth. In response, Seoul trading saw Samsung shares spike over 3% on the news, outperforming the broader Kospi indexreuters.cominvesting.com. As one market observer noted, “the third-quarter earnings surprise came from the chip business,” reflecting a turnaround for Samsung’s most important profit centerreuters.com. The key driver of Samsung’s earnings beat was the memory chip supercycle fueled by AI. Conventional DRAM and NAND memory prices have surged globally as data centers scramble for capacity, tightening supply. Samsung’s device solutions unit saw record quarterly sales, up about 19% from Q2gurufocus.com. Executives told analysts the AI boom is far outpacing capacity: Samsung Memory Chief Kim Jaejune warned that “customers’ demand for the next year will exceed our supply, even considering our investment and capacity expansion plan”reuters.com. He added that demand would be “much stronger and faster than usual”, implying continuing price gains. To capitalize, Samsung
30 October 2025
····
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

Alphabet (GOOG) Hits Record High on Q3 Earnings Beat, AI Boom Fueling Rally

Alphabet Inc.’s stock is on a tear heading into late October 2025. After this week’s earnings blowout, Alphabet’s Class C shares surged to roughly $270, marking a fresh all-time highreuters.com. On October 20, the stock had already closed at a record ~$256, valuing the Google parent near the elite $3 trillion market-cap clubts2.tech. Now, with the post-earnings pop, Alphabet firmly joins Apple and Microsoft among tech’s $3 trillion heavyweights. Year-to-date, the stock has climbed about 30%, dramatically outpacing the S&P 500’s ~12% gaints2.tech. For context, Alphabet’s rally has made it one of 2025’s top-performing mega-cap tech stocks. This momentum has accelerated over the past week. Investors bid shares higher in anticipation of strong results – Alphabet was up ~3% in the week leading into earningsts2.tech – and then the stock spiked further on the actual numbers. In after-hours trading following the Q3 report, GOOG jumped roughly 6%reuters.com. By midday Oct. 30, the shares were trading around their highest levels ever. Such strength shows traders’ enthusiasm for Alphabet’s direction, despite a few broader market wobbles in October. Even when the Nasdaq slid in early October amid interest-rate and geopolitical concerns, Alphabet’s stock only dipped briefly before rebounding to new highs the
30 October 2025
····
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Craters After Tepid Q3 Earnings – What’s Next for CMG?

Chipotle’s official earnings release confirmed a mixed quarter. Revenue rose to $3.0 billion but narrowly missed expectations, as comp sales growth failed to offset weaker trafficts2.techir.chipotle.com. EPS came in at $0.29, beating last year’s $0.28ir.chipotle.com but just matching analysts’ consensusmarketbeat.com. The report noted softer transactions – partly self-inflicted and largely driven by budget-conscious consumers – among households earning
30 October 2025
···
Fiserv Earnings Miss Expectations, Shares Slide – What’s Next for the Fintech Giant?

Shock Selloff: Fiserv (FI) Stock Plunges 40% After ‘Shockingly Bad’ Q3, Major Shakeup Unveiled

On Oct. 29, Fiserv reported a severely underwhelming third quarter. Adjusted EPS was just $2.04, about $0.60 below analyst forecasts, on revenue of $4.92B vs. $5.36B expectedng.investing.com. In GAAP terms, earnings were $1.46 and revenue $5.26Bts2.tech, boosted by one-time items last year, but these obscured weakening core trends. Organic growth virtually stalled after mid-single-digit gains in Q2ts2.tech. Fiserv cited a steep fall in its Argentine peso business and softer merchant volumes for the shortfall. CEO Mike Lyons – on the job only since May – acknowledged the miss was “not where we want it to be nor where our stakeholders expect it to be”ts2.tech. In tandem with the report, management slashed full-year guidance. Fiserv now forecasts just 3.5–4% revenue growth in 2025 and $8.50–$8.60 in adjusted EPS, down from prior targets of ~10% growth and ~$10.20 EPSreuters.com. Lyons said the firm ran “unrealistic” assumptions on volume and new product launches; he’s rolling out a “One Fiserv” turnaround plan to refocus on sustainable, client-first growthts2.techpaymentsdive.com. In effect, Fiserv is shifting away from costly short-term initiatives toward a more disciplined strategy. As CFO Bob Hau put it, the reset reflects “aligning structural versus cyclical growth” and will “negatively impact near-term results”paymentsdive.com.
30 October 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Alphabet Stock Skyrockets on AI Frenzy – Is $300 Next?

Key Facts: - Alphabet’s Class A shares traded around $274.6 on Oct. 30, 2025reuters.com, up from ~$267.5 on Oct. 28investing.com. The stock is about +30% year-to-datets2.tech and recently flirted with an all-time hights2.tech. - Q3 2025 results: Alphabet reported revenue of $102.3 billion and GAAP EPS of $2.87investopedia.coms206.q4cdn.com, easily beating Wall Street estimates. Google Services grew ~14%, and Google Cloud surged ~34% to $15.2Bs206.q4cdn.com. - Business growth: Google Search ad revenue rose about 12% YoY in Q3, and YouTube ad sales grew similarlyreuters.com, driving total ad revenue of roughly $65.9Breuters.com. Google Cloud continues its rapid expansion, keeping pace with Microsoft and Amazon. - AI and products: Alphabet is plowing huge capital into AI and new offerings. In early October it unveiled AI-powered Pixel 10 phones, Pixel Watch 4, etc., and announced ~$24B in new AI/cloud projectsts2.tech. CEO Sundar Pichai hailed Q3 as “our first-ever $100 billion quarter,” crediting widespread momentums206.q4cdn.com. - Analyst outlook: Wall Street is mostly bullish. About 80% of analysts rate GOOGL a Buyts2.tech. The consensus 12-month target is around the mid-$200sts2.tech, though many firms see more room to runts2.tech. Regulatory and macro risks temper some expectations, but key growth drivers remain strong. Alphabet’s stock has been on
30 October 2025
··
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Nears All-Time High on AI, Cloud Boom – Is $625 Next?

Microsoft’s October surge reflects both its recent execution and investor anticipation. The strong Q1 results and aggressive AI/cloud investments have boosted confidence. As Barclays noted about the OpenAI news, the company is “putting down all its chips to bet on AI’s future”reuters.com, and many analysts expect this to pay off. While valuations are lofty, Wall Street consensus remains overwhelmingly bullish. Even cautious voices admit Microsoft’s diverse revenue streams and cash flows justify a premiumts2.tech. Going forward, analysts will watch closely for signs of sustained cloud growth and how Microsoft manages rising capex. The combination of secular AI demand, expanded cloud offerings, and a loyal enterprise base gives Microsoft a clear runway. Barring any surprises, most experts believe MSFT could extend its rally – many price targets imply another 15–20% upside in the next 12 months. Sources: Company press releaseprnewswire.comprnewswire.com; Reuters and financial newsreuters.comreuters.comglobalbankingandfinance.com; TS2.tech analysists2.techts2.techts2.tech; Investing.cominvesting.cominvesting.com; StockAnalyst/MarketBeat datamarketbeat.comstockanalysis.com.
30 October 2025
··········
MP Materials Stock Soars on Pentagon and Apple Breakthroughs – 400% YTD Rally Explained

MP Materials Stock Surges on Rare-Earth Export Truce – Analysts Weigh In

Key Facts: MP Materials closed at $64.29 on Oct. 29, 2025markets.financialcontent.com, after retreating from mid-October highs. The stock has soared roughly 300–380% YTDts2.techreuters.com. It traded as high as $100.25 in mid-October, but recent U.S.–China trade news sent it back to the mid-$60s. MP’s huge 2025 gains reflect a string of catalysts: a $400M U.S. Defense Dept. investment with a $150M loan and guaranteed rare-earth magnet offtakets2.tech, plus a $500M deal to supply Apple with rare-earth magnetsreuters.com. Those deals helped the stock surge 20% on the Apple announcementreuters.com. In contrast, recent concerns over a U.S.–China trade truce led MP shares to fall ~7% on Oct. 27tipranks.commarkets.financialcontent.com. Analysts remain mostly bullish: MarketBeat shows a “Moderate Buy” consensus with a 12-month average target of $77.80marketbeat.com, though price targets range $64–$112marketbeat.com. After rocketing higher all year, MP’s stock has moderated recently. It hit multi-year highs in mid-October but pulled back as news of a U.S.–China deal surfaced. Data from Nasdaq shows MP closed $65.57 on Oct. 27, then $64.94 on Oct. 28 and $64.29 on Oct. 29markets.financialcontent.com. Intra-day Oct. 27, MP fell about 7.4%markets.financialcontent.com when reports emerged that China would likely maintain rare-earth export curbs. By early Oct. 30, MP was trading in the
30 October 2025
·
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Powell’s Hawkish U-Turn and Trump–Xi ‘Mini-Deal’ Leave S&P 500 Futures on Edge

S&P 500 futures hovered near their recent highs on Thursday as Wall Street digested a tug-of-war between dovish Fed policy and new uncertainties. Early Oct 30 trading showed futures almost unchanged, mirroring Wednesday’s close around 6,890.59reuters.com. Markets had rallied into Wednesday, with the Nasdaq hitting a fresh peak and the S&P near its own record, on hopes the Fed would continue cutting rates and on positive tech news. But Fed Chair Jerome Powell’s press conference after the Oct 29 meeting cooled those hopes. At the Federal Open Market Committee meeting Oct 29, the Fed delivered a widely expected 25-basis-point rate cutreuters.com and signaled an end to quantitative tightening. Stocks initially jumped on the move, but Powell’s emphasis that any December cut “is not a foregone conclusion” sliced into the rally. Traders slashed their odds of a Dec cut from roughly 90% to about 70% in a matter of hoursreuters.com. U.S. futures, which had been comfortably above fair value earlier, turned flat to slightly lower. In real-time, the S&P 500 index gave back its modest intraday gain after Powell spoke, closing essentially unchanged on Wednesdayreuters.com.
30 October 2025
·······
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock on Fire: GLP-1 Bonanza, Big Earnings & AI Pivot Drive Rally

Eli Lilly’s stock has been on a tear this year, driven by blockbuster drug sales and upbeat guidance. As of Oct. 29, 2025, LLY traded near $813.53investing.com. After hitting highs in the mid-$850s in early October, the shares have pulled back modestly. Trading volume and technical indicators suggest a consolidation phase after the recent rallyintellectia.aiintellectia.ai. Over the past 12 months LLY has significantly outperformed the broader market, in large part thanks to its GLP-1 diabetes/obesity franchise. Wall Street now assigns it a Moderate Buy consensus; 25 analysts have issued price targets totaling an average ~$938.61marketbeat.com. A Nasdaq/Fintel report noted an average one-year target near $904nasdaq.com. In short, most experts see further upside, though Lilly’s high valuation leaves little margin for error.
30 October 2025
···
Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta Stock Skyrockets on AI Push – Will It Keep Soaring?

Overall, Meta’s late-2025 story is one of high stakes and high hopes. Its core advertising machine is booming, and investors have cheered the aggressive AI and hardware bets. The company is locking in massive infrastructure and talent today, banking on big payoffs tomorrow. Whether all that spending will translate into sustained user growth and new revenue streams remains to be seen. But for now, most analysts remain on board, believing Meta’s 3-billion-user ecosystem and deep pockets make it a powerful player in the AI erats2.techts2.tech. Sources: Company filings and earnings reports; TechStock² analysests2.techafrica.businessinsider.com; Reuters and Business Insider market coveragets2.techreuters.comreuters.comafrica.businessinsider.com; Visible Alpha/analyst surveys.
30 October 2025
··
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 30.10.2025

ENDEDLive coverage has endedEnded: October 31, 2025, 12:00 AM EDT Liberty Latin America (LILA) Valuation Under Scrutiny as Shares Slide Despite Solid Fundamentals October 30, 2025, 10:36 PM EDT. Liberty Latin America (LILA) has fallen ~6% over the last month despite solid annual revenue growth and a rebound in net income. Its 1-year total shareholder return is down >20%, even after a strong rally earlier this year and a ~21% YTD gain. The stock trades at a discount to analyst targets, with a fair value around $10.63 versus a recent close near $7.77, suggesting an undervalued setup for patient investors.
30 October 2025
·······
Diageo Stock on the Rocks After 30% Slide – Is a Comeback Brewing for LSE: DGE?

Diageo Stock on the Rocks After 30% Slide – Is a Comeback Brewing for LSE: DGE?

Diageo’s share price has had a turbulent 2025, plunging nearly one-third year-to-date amid repeated disappointments. As of October 30, 2025, the stock traded around 1,755–1,760 pence, roughly flat with the prior day’s close after a modest mid-week uptick. That leaves the maker of Johnnie Walker whisky and Guinness beer down over 30% for the year – a stark contrast to the broader market upswing. In fact, Diageo has been one of the FTSE 100’s laggards, having lost about 30% of its value in 2025 alone. Investors who cheered a brief 6.5% share bounce after summer earnings saw those gains fizzle out by autumn, as macroeconomic worries returned. Short-term performance remains lackluster. The stock is hovering near levels not seen in years – about 50% below its all-time highs from 2021. Traders note that Diageo’s defensive qualities have offered little shelter this year, as rising interest rates and shrinking consumer spending power eroded its appeal. Notably, Diageo underperformed not just the UK index but also global benchmarks – trailing the S&P 500 by roughly 45–50 percentage points over the last 12 months. This indicates that the sell-off is both company-specific and part of a wider rotation out of consumer staple stocks
30 October 2025
·
Klarna (KLAR) Stock Dives Below IPO Level – Analysts Eye 30%+ Rebound

Klarna’s Wild Post-IPO Ride: Stock Slump, New Deals & Experts Predict What’s Next

Klarna’s New York IPO marked one of the year’s biggest fintech debuts. Priced at $40 per share, the offering raised about $1.37 billion and valued the Swedish BNPL leader at roughly $15 billionts2.tech. This valuation, while only one-third of Klarna’s pandemic-era $45.6 B peak, was more than double its 2022 low of $6.7 B after tech markets crashedts2.tech. The IPO was oversubscribed and priced above the initial $35–$37 range, reflecting pent-up investor demand. “$15 billion is far from disappointing”, noted Samuel Kerr, a market expert, given it topped Klarna’s target range and left investors “wanting more”reuters.com. Klarna’s CEO Sebastian Siemiatkowski didn’t sell shares, signaling confidencereuters.com. Trading kicked off with a bang – Klarna’s stock opened at $52 amid frenzied tradingreuters.com. That first-day pop valued Klarna near $19.7 Breuters.com and underscored a thawing IPO market. Klarna’s CFO celebrated the listing as an opportunity for its 111 million users and new shareholders to “partake in [Klarna’s] journey to disrupt financial services”reuters.com. The IPO also boosted confidence in U.S. listings after a dry spell – Klarna became the largest Swedish firm to list in New York since Spotify in 2018reuters.com.
30 October 2025
···
1 … 235 236 237 238 239 … 396
Go toTop